Moolec Science (MLEC) Enterprise Value (2022 - 2026)
Moolec Science (MLEC) reported Enterprise Value of -$1.2 million for Q1 2026, down 124.18% sequentially from $5.0 million in Q4 2025.
Moolec Science (MLEC) Enterprise Value (2022 - 2026) Analysis & Trends
Moolec Science (MLEC) has 5 years of Enterprise Value data on file, last reported at -$1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value changed N/A year-over-year to -$1.2 million; the trailing twelve-month figure through Mar 2026 stood at -$1.2 million (changed N/A YoY), and the FY2025 full-year result was -$26.1 million, down 114.42% from the prior year.
- Enterprise Value slipped to -$1.2 million in Q1 2026, from $5.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $185.4 million in Q2 2023 to a low of -$228.0 million in Q1 2023.
- A 5-year average of -$3.2 million and a median of -$4.3 million in 2024 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 615.98% in 2023, while the deepest fall reached 373.64% in 2023.
- Tracing MLEC's Enterprise Value over 5 years: stood at -$10.4 million in 2022, then tumbled by 373.64% to -$49.4 million in 2023, then retreated by 7.28% to -$53.0 million in 2024, then surged by 109.37% to $5.0 million in 2025, then slumped by 124.18% to -$1.2 million in 2026.
- Business Quant data shows MLEC's Enterprise Value at -$1.2 million in Q1 2026, $5.0 million in Q4 2025, and -$26.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 472.06 Bn | 467.27 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 122.10 Bn | 114.85 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.25 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.50 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - | -1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.20 Mn |
| Dec 31, 2025 | 4.96 Mn |
| Jun 30, 2025 | -26.12 Mn |
| Dec 31, 2024 | -52.99 Mn |
| Sep 30, 2024 | -3.61 Mn |
| Jun 30, 2024 | 181.13 Mn |
| Mar 31, 2024 | -4.25 Mn |
| Dec 31, 2023 | -49.40 Mn |
| Sep 30, 2023 | -853,857.00 |
| Jun 30, 2023 | 185.41 Mn |
| Mar 31, 2023 | -228.00 Mn |
| Dec 31, 2022 | -10.43 Mn |
| Jun 30, 2022 | -35.93 Mn |